致病性E139D突变稳定了多域酸酶SHP2的非正规活性状态
Anne E van Vlimmeren1,2, Ziyuan Jiang1, Deepti Karandur3
1Department of Chemistry, Columbia University, New York, New York, USA.
Protein science : a publication of the Protein Society
|November 13, 2025
概括
酸酶SHP2的调节失调,涉及到疾病,通过一种新的活性构造来澄清. 这项研究揭示了通过E139D突变SHP2过活化的新机制,影响其脂蛋白结合偏好.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- SHP2酸酶失调与先天性疾病和癌症有关.
- SHP2的N-SH2域自动抑制其PTP域,但疾病突变往往会破坏这种相互作用.
- E139D突变是个例外,存在于C-SH2域中,不适合已知的过度激活机制.
研究的目的:
- 为了阐明由E139D突变激活SHP2的机制.
- 为了确定SHP2.2的替代活性构造.
- 了解E139D突变如何改变SHP2的蛋白结合.
主要方法:
- 使用AlphaFold2.2.进行计算建模.
- 分子动力学模拟.分子动力学模拟.
- 双重突变周期分析.
主要成果:
- 确定了另一种活性SHP2构造,涉及Glu139与N-SH2域相互作用.
- 这种形状由E139D突变稳定.
- 与其他过度活跃的SHP2突变相比,E139D突变诱导了明显的蛋白结合偏好.
结论:
- 揭示了一种新的SHP2失调机制,涉及由E139D突变稳定的替代性活性构造.
- 这一发现为与SHP2相关的疾病提供了新的见解.
- 这项研究强调了结构动态在理解酶调节方面的重要性.
相关概念视频
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
Amplifying Signals via Enzymatic Cascade
17.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K


